Specifically, the CD34+ median expression levels were 0.040 (IQR 0.030–0.046) among MS and 0.023 (IQR 0.020–0.026) among CTRL (p = 0.0004), whereas the CD133+ median expression levels were 0.233 (IQR 0.020–0.030) in the MS group and 0.016 (IQR 0.013–0.020) in the CTRL group (p = 0.0109). This evidence concerns the gene CD34 and myeloid sarcoma.